Mohsen, Mona O.
Bachmann, Martin F.
Article History
Received: 18 April 2022
Accepted: 17 June 2022
First Online: 12 August 2022
Competing interests
: MFB is a board member of Saiba AG and holds the patent of CuMV<sub>TT</sub>. MOM received payments from Saiba AG to work on the development of vaccines against Dengue and SARS-CoV-2. MFB and MOM are shareholders of Saiba AGĀ and DeepVax GmbH.